Effects of interventions promoting monitoring of medication use and brief messaging on medication adherence for people with Type 2 diabetes: A systematic review of randomized trials

Diabetic Medicine

Volumn 33, Issue 5, 2016, Pages 565-579

  Farmer, A J ^a   Mcsharry, J ^b,c   Rowbotham, S ^c   Mcgowan, L ^c   Ricci Cabello, I ^a   French, D P ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; ORAL ANTIDIABETIC AGENT; RAMIPRIL; ROSUVASTATIN; SIMVASTATIN; ANTIDIABETIC AGENT;

ARTICLE; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED PROBLEM SOLVING; COMPUTER ASSISTED SELF MANAGEMENT; DEPRESSION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE PERSONNEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MEAN ARTERIAL PRESSURE; MEDICATION COMPLIANCE; MEDICATION THERAPY MANAGEMENT; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ONLINE MONITORING; PATIENT COMPLIANCE; PATIENT MONITORING; PROBLEM SOLVING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REMOTE SENSING; SELF CARE; SELF REPORT; SYSTEMATIC REVIEW; TELEMONITORING; TEXT MESSAGING; WEB BASED FEEDBACK; WEIGHT CONTROL; AMBULATORY MONITORING; DIABETES MELLITUS, TYPE 2; DRUG MONITORING; EVIDENCE BASED MEDICINE; INTERNET; MIDDLE AGED; PATIENT EDUCATION; PERSONALIZED MEDICINE; PSYCHOLOGICAL FEEDBACK; PSYCHOLOGICAL THEORY; TELEPHONE;

DIABETES MELLITUS, TYPE 2; DRUG MONITORING; EVIDENCE-BASED MEDICINE; FEEDBACK, PSYCHOLOGICAL; HUMANS; HYPOGLYCEMIC AGENTS; INTERNET; MEDICATION ADHERENCE; MIDDLE AGED; MONITORING, AMBULATORY; PATIENT EDUCATION AS TOPIC; PRECISION MEDICINE; PSYCHOLOGICAL THEORY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELF REPORT; TELEPHONE; TEXT MESSAGING;

EID: 84947236669     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12987     Document Type: Article

References (69)

1. Hertz RP, Unger AN, Lustik MB. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Clin Ther 2005; 27: 1064-1073.
2. Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care 2004; 27: 2800-2805.
3. Egede LE, Gebregziabher M, Dismuke CE, Lynch CP, Axon RN, Zhao Y et al. Medication Nonadherence in Diabetes: Longitudinal effects on costs and potential cost savings from improvement. Diabetes Care 2012; 35: 2533-2539.
4. Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2014; 11: CD000011.
5. Wens J, Vermeire E, Hearnshaw H, Lindenmeyer A, Biot Y, Van Royen P. Educational interventions aiming at improving adherence to treatment recommendations in type 2 diabetes: A sub-analysis of a systematic review of randomised controlled trials. Diabetes Res Clin Pract 2008; 79: 377-388.
6. Sapkota S, Brien JA, Greenfield J, Aslani P. A systematic review of interventions addressing adherence to anti-diabetic medications in patients with type 2 diabetes-impact on adherence. PLoS One 2015; 10: e0118296.
7. Omran D, Guirguis LM, Simpson SH. Systematic Review of Pharmacist Interventions to Improve Adherence to Oral Antidiabetic Medications in People with Type 2 Diabetes. Can J Diabetes 2012; 36: 292-299.
8. Lindenmeyer A, Hearnshaw H, Vermeire E, Van Royen P, Wens J, Biot Y. Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists. J Clin Pharm Ther 2006; 31: 409-419.
9. Doggrell SA. Does intervention by an allied health professional discussing adherence to medicines improve this adherence in Type 2 diabetes? Diabet Med 2010; 27: 1341-1319.
10. Sapkota S, Brien JA, Greenfield JR, Aslani P. A Systematic Review of Interventions Addressing Adherence to Anti-Diabetic Medications in Patients with Type 2 Diabetes-Components of Interventions. PLoS One 2015; 10: e0128581.
11. Graziano JA, Gross CR. The effects of isolated telephone interventions on glycemic control in type 2 diabetes: a literature review. ANS Adv Nurs Sci 2009; 32: E28-41.
12. van Dam HA, van der Horst FG, Knoops L, Ryckman RM, Crebolder HF, van den Borne BH. Social support in diabetes: a systematic review of controlled intervention studies. Patient Educ Couns 2005; 59: 1-12.
13. Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci 2011; 6: 42.
14. Free C, Phillips G, Galli L, Watson L, Felix L, Edwards P et al. The effectiveness of mobile-health technology-based health behaviour change or disease management interventions for health care consumers: a systematic review. PLoS Med 2013; 10: e1001362.
15. de Tolly K, Skinner D, Nembaware V, Benjamin P. Investigation into the use of short message services to expand uptake of human immunodeficiency virus testing, and whether content and dosage have impact. Telemed J E Health 2012; 18: 18-23.
16. Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet 2010; 376: 1838-1845.
17. Leon N, Surender R, Bobrow K, Muller J, Farmer A. Improving treatment adherence for blood pressure lowering via mobile phone SMS-messages in South Africa: a qualitative evaluation of the SMS-text Adherence SuppoRt (StAR) trial. BMC Fam Pract 2015; 16: 80.
18. Heron KE, Smyth JM. Ecological Momentary Interventions: Incorporating Mobile Technology Into Psychosocial and Health Behavior Treatments. Br J Health Psychol 2010; 15: 1-39.
19. Miklowitz DJ, Price J, Holmes EA, Rendell J, Bell S, Budge K et al. Facilitated Integrated Mood Management for adults with bipolar disorder. Bipolar Disord 2012; 14: 185-197.
20. Carrasco MP, Salvador CH, Sagredo PG, Marquez-Montes J, Gonzalez de Mingo MA, Fragua JA et al. Impact of patient-general practitioner short-messages-based interaction on the control of hypertension in a follow-up service for low-to-medium risk hypertensive patients: a randomized controlled trial. IEEE Trans Inf Technol Biomed 2008; 12: 780-791.
21. Kass MA, Meltzer DW, Gordon M. A miniature compliance monitor for eyedrop medication. Arch Ophthalmol 1984; 102: 1550-1554.
22. Derose SF, Green K, Marrett E, Tunceli K, Cheetham TC, Chiu VY et al. Automated outreach to increase primary adherence to cholesterol-lowering medications. JAMA Intern Med 2013; 173: 38-43.
23. Farmer A, Kinmonth AL, Sutton S. Measuring beliefs about taking hypoglycaemic medication among people with Type 2 diabetes. Diabet Med 2006; 23: 265-270.
24. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Ann Intern Med 2009; 151: 264-269.
25. Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WA et al. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev 2012; (1): CD005060.
26. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008; (2): CD000011.
27. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions: The Cochrane Collaboration; 2011. Available at http://www.cochrane-handbook.org. Last accessed 6 August 2015.
28. Olander EK, Fletcher H, Williams S, Atkinson L, Turner A, French DP. What are the most effective techniques in changing obese individuals' physical activity self-efficacy and behaviour: a systematic review and meta-analysis. Int J Behav Nutr Phys Act 2013; 10: 29.
29. Cassimatis M, Kavanagh DJ. Effects of type 2 diabetes behavioural telehealth interventions on glycaemic control and adherence: a systematic review. J Telemed Telecare 2012; 18: 447-450.
30. Ryan R, Santesso N, Lowe D, Hill S, Grimshaw J, Prictor M et al. Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews. Cochrane Database Syst Rev 2014; (4): CD007768.
31. Vervloet M, Linn AJ, van Weert JCM, de Bakker DH, Bouvy ML, van Dijk L. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc 2012; 19: 696-704.
32. Williams JLS, Walker RJ, Smalls BL, Campbell JA, Egede LE. Effective interventions to improve medication adherence in Type 2 diabetes: a systematic review. Diabetes Manag (Lond) 2014; 4: 29-48.
33. Michie S, Prestwich A. Are interventions theory-based? Development of a theory coding scheme. Health Psychol 2010; 29: 1-8.
34. Fleiss JL, Levin B, Paik C. Statistical methods for rates and proportions (3rd edn). Chichester: John Wiley & Sons, 2013.
35. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
36. Cohen J. Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit. Psychol Bull 1968; 70: 213.
37. Rice J. Mathematical Statistics and Data Analysis. Cengage Learning 2006.
38. Deeks J, Higgins J, Altman D. Chapter 9-Analysing Data and Undertaking Meta-analyses. The Cochrane Collaboration; 2011. Available at: http://www.cochrane-handbook.org. Last accessed 6 August 2015.
39. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
40. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
41. Arora S, Peters AL, Burner E, Lam CN, Menchine M. Trial to examine text message-based mHealth in emergency department patients with diabetes (TExT-MED): a randomized controlled trial. Ann Emerg Med 2014; 63: 745-754.
42. Brath H, Morak J, Kastenbauer T, Modre-Osprian R, Strohner-Kastenbauer H, Schwarz M et al. Mobile health (mHealth) based medication adherence measurement: a pilot trial using electronic blisters in diabetes patients. Br J Clin Pharmacol 2013; 76: 47-55.
43. Shetty AS, Chamukuttan S, Nanditha A, Raj RK, Ramachandran A. Reinforcement of adherence to prescription recommendations in Asian Indian diabetes patients using short message service (SMS): a pilot study. J Assoc Physicians India 2011; 59: 711-714.
44. Bogner HR, Morales KH, de Vries HF, Cappola AR. Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial. Ann Fam Med 2012; 10: 15-22.
45. Guldberg TL, Vedsted P, Kristensen JK, Lauritzen T. Improved quality of Type 2 diabetes care following electronic feedback of treatment status to general practitioners: a cluster randomized controlled trial. Diabet Med 2011; 28: 325-332.
46. Nesari M, Zakerimoghadam M, Rajab A, Bassampour S, Faghihzadeh S. Effect of telephone follow-up on adherence to a diabetes therapeutic regimen. Jpn J Nurs Sci 2010; 7: 121-128.
47. Odegard PS, Goo A, Hummel J, Williams KL, Gray SL. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother 2005; 39: 433-440.
48. Vervloet M, Dijk L, Santen-Reestman J, Vlijmen B, Wingerden P, Bouvy ML et al. SMS reminders improve adherence to oral medication in type 2 diabetes patients who are real time electronically monitored. Int J Med Inform 2012; 81: 594-604.
49. Vervloet M, van Dijk L, de Bakker DH, Souverein PC, Santen-Reestman J, van Vlijmen B et al. Short- and long-term effects of real-time medication monitoring with short message service (SMS) reminders for missed doses on the refill adherence of people with Type 2 diabetes: evidence from a randomized controlled trial. Diabet Med 2014; 31: 821-828.
50. Vervloet M, van Dijk L, Santen-Reestman J, van Vlijmen B, Bouvy ML, de Bakker DH. Improving medication adherence in diabetes type 2 patients through Real Time Medication Monitoring: a Randomised Controlled Trial to evaluate the effect of monitoring patients' medication use combined with short message service (SMS) reminders. BMC Health Serv Res 2011; 11: 5.
51. Wakefield BJ, Holman JE, Ray A, Scherubel M, Adams MR, Hillis SL et al. Effectiveness of home telehealth in comorbid diabetes and hypertension: a randomized, controlled trial. Telemed J E Health 2011; 17: 254-261.
52. Wakefield BJ, Holman JE, Ray A, Scherubel M, Adams MR, Hills SL et al. Outcomes of a home telehealth intervention for patients with diabetes and hypertension. Telemed J E Health 2012; 18: 575-579.
53. Fisher L, Hessler D, Glasgow RE, Arean PA, Masharani U, Naranjo D et al. REDEEM: a pragmatic trial to reduce diabetes distress. Diabetes Care 2013; 36: 2551-2558.
54. Glasgow R, Christiansen SM, Kurz D, King DK, Woolley T, Faber AJ et al. Engagement in a diabetes self-management website: usage patterns and generalizability of program use. J Med Internet Res 2011; 13: e9.
55. Glasgow RE, Kurz D, King D, Dickman JM, Faber AJ, Halterman E et al. Outcomes of minimal and moderate support versions of an internet-based diabetes self-management support program. J Gen Intern Med 2010; 25: 1315-1322.
56. Glasgow RE, Kurz D, King D, Dickman JM, Faber AJ, Halterman E et al. Twelve-month outcomes of an Internet-based diabetes self-management support program. Patient Educ Couns 2012; 87: 81-92.
57. Janz NK, Becker MH. The Health Belief Model: A Decade Later. Health Educ Q 1984; 11: 1-47.
58. Bogner HR, de Vries HF. Integration of depression and hypertension treatment: a pilot, randomized controlled trial. Ann Fam Med 2008; 6: 295-301.
59. Fishbein M, Ajzen I. Belief, attitude, intention and behavior: An introduction to theory and research. Reading, MA: Addison-Wesley Pub, 1975.
60. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 1977; 84: 191-215.
61. Leventhal H, Cameron L. Behavioral theories and the problem of compliance. Patient Educ Couns 1987; 10: 117-138.
62. Garfield S, Clifford S, Eliasson L, Barber N, Willson A. Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med Res Methodol 2011; 11: 149.
63. Hearnshaw H, Lindenmeyer A, Vermeire E, Van Royen P, Wens J, Biot Y. Interventions to improve adherence to medication in people with type 2 diabetes mellitus: the role of nurses. EDN 2006; 3: 73-77.
64. Vermeire E, Wens J, Van Royen P, Biot Y, Hearnshaw H, Lindenmeyer A. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005; (2): CD003638.
65. Fairman K, Matheral B. Evaluating medication adherence: which measure is right for your program? JMPC 2000; 6: 4.
66. Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012; 73: 691-705.
67. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999; 21: 1074-1090.
68. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008; 337: a1655.
69. Michie S, Abraham C. Interventions to change health behaviours: evidence-based or evidence-inspired? Psychol Health 2004; 19: 29-49.